- Audrey Bowen, senior lecturer in psychology1,
- Anne Hesketh, clinical senior lecturer in speech and language therapy1,
- Emma Patchick, trial manager1,
- Alys Young, professor of social work education and research2,
- Linda Davies, professor of health economics3,
- Andy Vail, senior lecturer in biostatistics4,
- Andrew F Long, professor of health systems research5,
- Caroline Watkins, professor of stroke and older people’s care, chair of UK Forum for Stroke Training6,
- Mo Wilkinson, visitor monitor1,
- Gill Pearl, speech and language therapist7,
- Matthew A Lambon Ralph, professor of cognitive neuroscience8,
- Pippa Tyrrell, professor of stroke medicine9
- 1HCD, Ellen Wilkinson Building, University of Manchester, Manchester Academic Health Science Centre (MAHSC), Manchester M13 9PL, UK
- 2Jean McFarlane Building, University of Manchester MAHSC
- 3Manchester Health Sciences Research Group: Health Economics, Jean MacFarlane Building, University of Manchester MAHSC
- 4University of Manchester MAHSC, R&D Support Unit, Salford Royal NHS Foundation Trust, Salford, UK
- 5School of Healthcare, University of Leeds, Leeds, UK
- 6Clinical Practice Research Unit, University of Central Lancashire, Preston, UK
- 7Speakeasy, c/o 2 Purbeck Drive, Bolton, UK
- 8NARU, University of Manchester MAHSC
- 9University of Manchester MAHSC, Salford Royal NHS Foundation Trust
- audrey.bowen{at}manchester.ac.uk
It is encouraging to see the Royal College of Speech and Language Therapists supporting randomised controlled trials (RCTs).1 2 Meteyard worries that RCTs will not cope with the complexity inherent after stroke.3 However, many RCTs have demonstrated the effectiveness of a range of complex interventions for heterogeneous populations (for example, stroke unit care, occupational therapy).
As Enderby notes, the Cochrane review finds …
PDF
Social bookmarking